论文部分内容阅读
目的探讨银杏达莫注射液与东菱克栓酶联合治疗急性脑梗死的临床疗效。方法74例急性脑梗死患者随机分为两组;观察组43例,采用银杏达莫注射液+东菱克栓酶治疗;对照组31例,采用东菱克栓酶治疗。分别在治疗前及治疗后对两组患者的神经功能缺损程度及生活状态进行评分。结果观察组有效率为83.7%,明显高于对照组的67.7%;观察组治疗后的神经功能缺损程度及生活状态的改善明显优于对照组。结论银杏达莫注射液与东菱克栓酶联合治疗急性脑梗死安全有效。
Objective To investigate the clinical efficacy of gingko Damo injection and tamarin combined treatment of acute cerebral infarction. Methods A total of 74 patients with acute cerebral infarction were randomly divided into two groups: 43 cases in the observation group were treated with gingko Damo Injection + Lingling Kexue and 31 cases in the control group. The levels of neurological deficits and living conditions in both groups before and after treatment were scored. Results The effective rate of the observation group was 83.7%, which was significantly higher than that of the control group (67.7%). The degree of neurological deficits and the improvement of living conditions in the observation group were significantly better than those in the control group. Conclusions Ginkgo biloba injection combined with batroxobin is safe and effective in the treatment of acute cerebral infarction.